For citations:
Nedogoda S.V., Salasyuk A.S., Barikina I.N., Smirnova V.O., Frolov M.Yu. Economic evaluation of the fixed combination of insulin glargine and lixisenatide in Diabetes Mellitus type 2. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2019;(3):13-22. (In Russ.) https://doi.org/10.24411/2588-0519-2019-10079
Email this article 